Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling.

Sun D, Liu Y, Yu Q, Zhou Y, Zhang R, Chen X, Hong A, Liu J.

Biomaterials. 2013 Jan;34(1):171-80. doi: 10.1016/j.biomaterials.2012.09.031. Epub 2012 Oct 8.

PMID:
23059005
2.

Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.

Yang L, Zhang J, Wang C, Qin X, Yu Q, Zhou Y, Liu J.

Metallomics. 2014 Mar;6(3):518-31. doi: 10.1039/c3mt00237c. Epub 2013 Dec 16.

PMID:
24336978
3.

Effects of Pien Tze Huang on angiogenesis in vivo and in vitro.

Shen AL, Hong F, Liu LY, Lin JM, Zhuang QC, Hong ZF, Peng J.

Chin J Integr Med. 2012 Jun;18(6):431-6. doi: 10.1007/s11655-012-1121-z. Epub 2012 Jul 22.

PMID:
22821655
4.

Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.

PLoS One. 2012;7(12):e52279. doi: 10.1371/journal.pone.0052279. Epub 2012 Dec 31.

5.

Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.

Baek YY, Cho DH, Choe J, Lee H, Jeoung D, Ha KS, Won MH, Kwon YG, Kim YM.

Eur J Pharmacol. 2012 Jan 15;674(2-3):188-99. doi: 10.1016/j.ejphar.2011.11.022. Epub 2011 Nov 23.

PMID:
22130357
6.

Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.

Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. doi: 10.1152/ajpendo.90780.2008. Epub 2009 Apr 7.

7.

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.

Huang SW, Lien JC, Kuo SC, Huang TF.

Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

PMID:
22436611
8.

OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.

Omar HA, Arafa el-SA, Salama SA, Arab HH, Wu CH, Weng JR.

Toxicol Appl Pharmacol. 2013 Nov 1;272(3):616-24. doi: 10.1016/j.taap.2013.07.014. Epub 2013 Aug 3.

PMID:
23921148
9.
10.

Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.

Shen K, Ji L, Gong C, Ma Y, Yang L, Fan Y, Hou M, Wang Z.

Biochem Pharmacol. 2012 Sep 15;84(6):784-92. doi: 10.1016/j.bcp.2012.05.024. Epub 2012 Jul 4.

PMID:
22771629
12.

Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.

Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L, Walzog B, Pohl U, Krotz F.

J Vasc Res. 2008;45(2):153-63. Epub 2007 Oct 25.

PMID:
17962719
13.

Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles.

Sun D, Liu Y, Yu Q, Qin X, Yang L, Zhou Y, Chen L, Liu J.

Biomaterials. 2014 Feb;35(5):1572-83. doi: 10.1016/j.biomaterials.2013.11.007. Epub 2013 Nov 20.

PMID:
24268198
14.

Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.

Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y.

Oncogene. 2009 Sep 24;28(38):3412-22. doi: 10.1038/onc.2009.189. Epub 2009 Jul 13.

PMID:
19597469
15.

Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.

Kunimasa K, Ikekita M, Sato M, Ohta T, Yamori Y, Ikeda M, Kuranuki S, Oikawa T.

Cancer Sci. 2010 Nov;101(11):2462-9. doi: 10.1111/j.1349-7006.2010.01668.x.

16.

Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.

Ren X, Dai M, Lin LP, Li PK, Ding J.

Br J Pharmacol. 2009 Apr;156(8):1228-38. doi: 10.1111/j.1476-5381.2009.00112.x. Epub 2009 Mar 19.

17.

Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.

Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.

J Ethnopharmacol. 2012 Jun 1;141(2):721-7. doi: 10.1016/j.jep.2011.08.052. Epub 2011 Sep 3.

PMID:
21911050
18.

Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.

Chang CH, Ou TT, Yang MY, Huang CC, Wang CJ.

J Ethnopharmacol. 2016 Jul 21;188:111-22. doi: 10.1016/j.jep.2016.05.012. Epub 2016 May 10.

PMID:
27178635
19.

Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells.

Wang S, Yoon YC, Sung MJ, Hur HJ, Park JH.

Biochem Biophys Res Commun. 2012 May 11;421(3):567-71. doi: 10.1016/j.bbrc.2012.04.046. Epub 2012 Apr 14.

PMID:
22525673
20.

FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.

Gao W, Jin K, Lan H, Han N, Cao F, Teng L.

Hepatogastroenterology. 2012 Nov-Dec;59(120):2543-7.

PMID:
22534543

Supplemental Content

Support Center